| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
STAT3 |
|
1.012 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.012 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
1.012 |
Evidence |
|
| KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
TRPV6 |
TRPV6, ECAC2: Transient receptor potential cation channel subfamily V member 6 |
1.012 |
Evidence |
|
| KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
1.012 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
1.012 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.012 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.012 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
1.012 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
MAX |
MAX: Protein max |
1.012 |
Evidence |
|
| HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.012 |
Evidence |
|
| HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
1.012 |
Evidence |
|
| HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPINI1 |
SERPINI1, PI12: Neuroserpin precursor |
1.012 |
Evidence |
|
| HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
1.012 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.012 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.012 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
TFAP4 |
TFAP4: Transcription factor AP-4 |
1.012 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
1.012 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
TRHR |
TRHR: Thyrotropin-releasing hormone receptor |
1.012 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
1.012 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
1.012 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
DRD1 |
DRD1: D(1A) dopamine receptor |
1.012 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
1.012 |
Evidence |
|
| MMP7 |
MMP7, MPSL1, PUMP1: Matrilysin precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
1.012 |
Evidence |
|
| F7 |
F7: Coagulation factor VII precursor |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
1.012 |
Evidence |
|